Vontobel Holding
HRMY icon

Vontobel Holding’s Harmony Biosciences HRMY Stock Holding History

Vontobel Holding’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,000
Closed -$211K – 1107
2024
Q2 		$211K Hold
7,000
– – ﹤0.01% 978
2024
Q1 		$235K Sell
7,000
-3,600
-34% -$116K ﹤0.01% 970
2023
Q4 		$342K Buy
10,600
+3,600
+51% +$100K ﹤0.01% 892
2023
Q3 		$229K Buy
+7,000
New +$243K ﹤0.01% 961
2021
Q4 		– Sell
-10,000
Closed -$383K – 1125
2021
Q3 		$383K Hold
10,000
– – ﹤0.01% 873
2021
Q2 		$282K Hold
10,000
– – ﹤0.01% 935
2021
Q1 		$330K Buy
+10,000
New +$351K ﹤0.01% 773

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vontobel Holding's HRMY Position: Q3 2024 in Review

Vontobel Holding sold out of Harmony Biosciences (HRMY) in Q3 2024, closing a stake of 7,000 shares — an estimated $211K sold.

Vontobel Holding first reported a position in HRMY in Q1 2021 and held it in 7 quarters. The position peaked at $383K in Q3 2021. 233 funds tracked by Wall St. Rank hold HRMY as of Q3 2024.

  • Vontobel Holding reported no remaining Harmony Biosciences position as of Q3 2024 after selling out during the quarter.
  • Vontobel Holding sold 7,000 Harmony Biosciences shares in Q3 2024, an estimated $211K.
  • Vontobel Holding first reported a position in Harmony Biosciences in Q1 2021 and held it in 7 quarters.
  • Vontobel Holding's Harmony Biosciences position peaked at $383K in Q3 2021.
  • 233 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2024.

Based on Vontobel Holding's 13F filing for Q3 2024, filed 16 Oct 2024.